Epithelial-mesenchymal transition in prostate cancer: an overviewMicaela Montanari, Gaetano Facchini|Oncotarget|2017Cited by 177
Assessment of Total, PTEN–, and AR-V7+ Circulating Tumor Cell Count by Flow Cytometry in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving EnzalutamideGiuseppe Di Lorenzo, Carlo Buonerba, Dario Ribera et al.|Clinical Genitourinary Cancer|2021Cited by 23
Results of TETimaX Trial of Langerhans Cell Histiocytosis Treatment and Perspectives on the Role of Imatinib Mesylate in the Era of MAPK SignalingLiliana Montella, Giovannella Palmieri, Margaret Ottaviano et al.|Biomedicines|2021Cited by 2